Characterising seizure cycles in pediatric epilepsy

Hannah Kamitakahara1, Philippa J Karoly2, Rachel E Stirling2

  • 1Seer Medical Pty Ltd, VIC, Australia.

PubMed

Insights

Multiday seizure cycles, similar in children and adults with epilepsy, can predict seizure timing. These findings offer a new way to manage epilepsy unpredictability in pediatric patients.

Area of Science:

  • Epilepsy research
  • Chronobiology
  • Pediatric neurology

Background:

  • Multiday cyclic patterns in seizure timing are known in adults with epilepsy.
  • Longer-term seizure patterns in pediatric epilepsy cohorts remain underexplored.
  • This study investigates multiday seizure cycles in pediatric and adult epilepsy patients.

Purpose of the Study:

  • To identify and compare multiday seizure cycles between pediatric and adult epilepsy cohorts.
  • To validate cycle-based methods for estimating seizure likelihood in pediatric epilepsy.

Main Methods:

  • Retrospective analysis of multiday seizure cycles from 325 electronic seizure diary users (71 pediatric).
  • K-means clustering grouped cycles; synchronization index quantified cycle strength.
  • Rayleigh test identified significant cycles; Wilcoxon rank-sum test compared cohorts; AUC calculated for model validation.

Main Results:

  • Analysis of 30,019 seizures revealed significant circadian, weekly, fortnightly, and monthly seizure cycles.
  • Prevalence and strength of these cycles did not differ between pediatric and adult cohorts.
  • Cycle-based models reliably predicted seizure occurrence, outperforming random models and moving average models.

Conclusions:

  • Multiday seizure cycles derived from seizure diaries are a viable method for understanding pediatric epilepsy patterns.
  • Identifying individual seizure cycles can decrease seizure unpredictability.
  • This approach has potential to inform clinical decision-making for epilepsy management.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.4K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.6K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
834
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
637
Brain Waves01:23

Brain Waves

Brain waves are electrical signals generated by the neurons in the brain, which are regularly monitored to measure mental activities. Brain waves and their frequency ranges can be measured using an electroencephalogram or EEG. There are four main types of brain waves, each with distinct characteristics:
3.9K